Michael A. Young, MHA, FACHE, President and CEO of Temple University Hospital and Temple University Health System, provided perspective to Becker’s Hospital Review on “one question that hospital CEOs need answered right now.”
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Anjali Vaidya Provides Perspective to Healio on FDA Filing Acceptance of New Drug Application for Ralinepag for Treatment of Pulmonary Arterial Hypertension
Posted August 28, 2026
Ralinepag is a once-daily oral prostacyclin for the treatment of pulmonary arterial hypertension (PAH).
View DetailsDr. Mohammed Chowdhury Provides Perspective to MedPage Today on New Drug to Prevent Worsening Pulmonary Arterial Hypertension
Posted August 6, 2026
Data found oral ralinepag significantly reduced the risk of first clinical worsening in low-risk patients with pulmonary arterial hypertension already receiving contemporary background therapy.
View Details